By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Breckenridge Pharmaceutical, Inc. 

1141 S. Rogers Circle
Suite 3
Boca Raton  Florida  33487  U.S.A.
Phone: 800-367-3395 Fax: 561-989-9747


SEARCH JOBS


Industry
Pharmaceutical






Company News
Breckenridge Pharmaceutical, Inc. Signs Marketing Agreement With Gland Pharma For Seven Injectable Products 12/6/2016 6:42:03 AM
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Armodafinil Tablets (CIV) In 50mg, 150mg And 250 Mg Strengths (Nuvigil) 11/29/2016 6:29:00 AM
Breckenridge Pharmaceutical, Inc. Announces Entry Into Injectable Market With The Immediate Launch Of Methylergonovine Maleate Injection 11/10/2016 3:18:10 PM
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Lacosamide Tablets (Vimpat) 5/4/2016 6:42:41 AM
Breckenridge Pharmaceutical, Inc. Announces Approval For Gabapentin Oral Solution 3/18/2016 6:30:29 AM
Breckenridge Pharmaceutical, Inc. Announces Final Approval For Dutasteride Soft Gelatin Capsules 11/20/2015 10:00:16 AM
Breckenridge Pharmaceutical, Inc. Announces Approval For Rabeprazole Sodium Delayed-Release Tablets 11/19/2015 11:12:48 AM
Breckenridge Pharmaceutical, Inc. Announces Tentative Approval For Dutasteride Soft Gelatin Capsules 9/14/2015 6:31:19 AM
Breckenridge Pharmaceutical, Inc. Announces Approval For Azelastine HCl Nasal Solution (Nasal Spray) 7/29/2015 11:48:30 AM
Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval For Desvenlafaxine XR Tablets (Pristiq) 7/2/2015 6:11:31 AM
123456
//-->